uniQure N.V. Ordinary Shares vs Ralph Lauren Corp — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B), while Ralph Lauren Corp trades at $377.26 (market cap $22.27B). The key difference: Ralph Lauren Corp is far larger — about 15.4× uniQure N.V. Ordinary Shares's market cap, and Ralph Lauren Corp pays a 1.07% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Ralph Lauren Corp for 84 Days on average.
| QURE | RL | |
|---|---|---|
Market Cap | $1.45B | $22.27B |
Volume | 3,323,243 | 320,311 |
Sector | Health | Consumer Cyclical |
52-Week High | $70.59 | $414.25 |
52-Week Low | $9.03 | $309.29 |
Typical Hold Time | 0 Days | 84 Days |
Enterprise Value | $707.46M | $23.33B |
Dividend Yield | — | 1.07% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Ralph Lauren (RL) trades at $373.75, up 0.14% on the day, with a bullish technical signal from moving averages and strong analyst support. The company shows robust fundamentals with revenue growth from $7.08B in 2025 to projected $8.4B in 2026, net income margin improving to 11.76%, and consistent earnings beats. Recent news highlights expansion efforts, AI integration, and a declared dividend, reinforcing positive momentum.
The outlook is favorable given earnings growth, luxury brand strength, and a consensus price target of $456.67 implying 22% upside. Risks include market volatility, competitive pressures, and execution of global strategies. Analyst sentiment is strongly bullish with 66.7% buy ratings, supporting a constructive view for investors seeking exposure to a growing apparel leader.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →Founded by designer Ralph Lauren in 1967, Ralph Lauren Corp. designs, markets, and distributes lifestyle products in North America, Europe, and Asia. Its products include apparel, footwear, eyewear, jewelry, leather goods, home products, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, Lauren Ralph Lauren, and Double RL. Distribution channels for Ralph Lauren include wholesale (including department stores and specialty stores), retail (including company-owned retail stores and e-commerce), and licensing.
Read more on RL →